Gap junctions and ion channels: Relevance to erectile dysfunction

International Journal of Impotence Research

Volumn 12, Issue , 2000, Pages S15-S25

  Christ, G J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Corporal myocyte; KATP channel; KCa channel; K+ channel gene therapy; Smooth muscle tone; Transmembrane potential

Indexed keywords

ION; POTASSIUM; PROSTAGLANDIN E1; SILDENAFIL;

CONFERENCE PAPER; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; GAP JUNCTION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN TISSUE; ION CHANNEL; MEMBRANE POTENTIAL; MUSCLE FIBER CONTRACTION; NONHUMAN; PATHOGENESIS; PENIS ERECTION; POTASSIUM CHANNEL; PRIORITY JOURNAL; SMOOTH MUSCLE TONE;

AGING; ANIMAL; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; GAP JUNCTIONS; GENE THERAPY; HUMAN; IMPOTENCE; ION CHANNELS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; POTASSIUM CHANNELS;

EID: 0033776875     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900573     Document Type: Article

References (106)

1. Christ GJ. The penis as a vascular organ: The importance of corporal smooth muscle tone in the control of erection. Urologic Clinics of North America 1995; 22: 727-745.
2. Melman A, Christ GJ. The vascular physiology of penile erection and pharmacotherapy erectile dysfunction. In: Frishman WH, Sonnenblick EH, eds. Cardiovascular Phar-macotherapeutics. McGraw-Hill: Ny, 1997, pp 1221-1229.
3. Christ GJ. Erection. The Encyclopedia of Reproduction. Academic Press: Ny, 1998, pp 38-49.
4. Christ GJ. The ‘syncytial tissue triad’: A model for understanding how gap junctions participate in the local control of penile erection. World J Urol 1997; 13: 36-44.
5. Christ GJ, Richards S, Winkler A. Integrative erectile biology: The role of signal transduction and cell-to-cell communication in coordinating corporal smooth muscle tone and penile erection. Int J Impot lies 1997; 9: 1-16.
6. Taub HC, Lerner SE, Melman A, Christ GJ. Relationship between contraction and relaxation in human and rabbit corpus cavernosum. Urology 1993: 42: 698-704.
7. Lerner SE, Melman A, Christ GJ. A review of erectile dysfunction: New insights and more questions. J Urol 1993; 149: 1246-1255.
8. Wagner G. Erection. In: Wagner G, Green R, eds. Impotence: Physiological, Psychological and Surgical Diagnosis and Treatment. Plenum Press: New York, 1981, pp 25-36.
9. Saenz De Tajada I et al. Impared neurogenic andendothe-lium-mediated relaxation of penile smooth muscle from diabetic mem with impotence. New Engl J Med 1989; 320: 1025.
10. Saenz De Tejada I et al. Trabecular smooth muscle modulates the capacitor function of the penis studies on a rabbit model. Am J Physiol 1991; 260: H1590-H1595.
11. Wagner G, Saenz De Tejada I. Update on male erectile dysfunction. Br Med J 1998; 316: 678-682.
12. Krane RJ, Goldstein I, Saenz De Tejada I. Medical progress: Impotence. New Engl J Med 1989; 321: 1648-1659.
13. Lue TF, Tanagho EA. Physiology of erection and pharmacologic management of impotence. J Urol 1987; 137: 829-836.
14. Andersson K-E, Wagner G. Physiology of penile erection. Physiological Reviews 1995; 75: 191-225.
15. Christ GJ. The control of corporal smooth muscle tone, the coordination of penile erection and the etiology of erectile dysfunction: The devil is in the details. J Sex Educat Ther 1998; 23: 187-193.
16. Linet IO et al. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The alprosladil study group. New Engl J Med 1996; 334: 873-877.
17. Mulhall JP et al. Intracavernosal forskolin: Role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. J Urol 1997; 158: 1752-1758.
18. Me Vary KT, Rathnau GH, McKenna KE. Sexual dysfunction in the diabetic BB/WOR rat: A role of central neuropathy. Am J Physiol 1997; 272: R259-R267.
19. McKenna KE. Central control of penile erection. Int J Impot lies 1998; 10(Suppl): S25-S34.
20. Bernabe J, Rampin O, Sachs BD, Guiliano F. Intracavernous pressure during erection in rats: An integrative approach based on telemetric recording. Am J Physiol 1999; 276: R441-R449.
21. Nofzinger EA. Sexual dysfunction in patients with diabetes mellitus: The role of a ‘central’ neuropathy. Semin Clin Neuropsychiatry 1997; 2: 31-39.
22. Speralakis N. Origin of resting membrane potentials. In: Speralakis N, (ed). Cell Physiology Source Book, 2nd edition. Academic Press: Ny, 1998, pp 178-206.
23. Christ GJ, Spray DC, Brink PR. Characterization of K currents in cultured human corporal smooth muscle cells. J Androl-ogy 1993; 14: 319-328.
24. Fan SF, Brink PR, Melinan A, Christ GJ. An analysis of the Maxi-K+ (KCa) channel in cultured human corporal smooth muscle cells. J Urol 1995; 153: 818-825.
25. Lee SW et al. Prostaglandin Ea activates the large conductance Kca channel in human corporal smooth muscle. Int J Impot lies 1999; 11: 179-188.
26. Lee SW, Wang H-Z, Christ GJ. Characterization of ATP-sensitive potassium channels in human corporal smooth muscle cells. Int J Impot Bes 1999; 11: 189-199.
27. Christ GJ, Richards S, Winkler A. Integrative erectile biology: The role of signal transduction and cell-to-cell communication in coordinating corporal smooth muscle tone and penile erection. Int J Impot Bes 1997; 9: 1-16.
28. Christ GJ et al. Transfection of rat corporal tissue in vivo with hSlo cDNA is associated with physiologically relevant alterations in erectile function. Am J Physiol 1998; 275: H600-H608.
29. Christ GJ et al. Ion channels and gap junctions: Their role in erectile physiology, dysfunction and future therapy. Mol Urology 1999; 3: 61-74.
30. Christ GJ, Melinan A. Molecular studies of human corporal smooth muscle: Implications for the understanding, diagnosis, and treatment of erectile dysfunction. Mol Urol 1997; 1: 45-54.
31. Christ GJ. A new frontier: Gene therapy for erectile dysfunction. In: Morales A, (ed). Current Concepts in the Treatment of Erectile Dysfunction, Martin Dunitz Publishers: London, 1998, pp 209-230.
32. Wang H-Z, Lee SW, Christ GJ. Electrophysiological evaluation of K+ channels in enzymatically dissociated myocytes from human and rat corpus cavernosuin. Int J Impot Bes 2000; 12: (In press).
33. Fan S-F, Christ GJ, Melinan A, Brink PR. A stretch-sensitive chloride channel in corpora cavernosa myocytes. Int J Impot Bes 1999; 11: 1-7.
34. Standen NB, Quayle JM. K+ channel modulation in arterial smooth muscle. Acta Physiol Scand 1998; 164: 549-557.
35. Jackson WF. Ion channels and vascular tone. Hypertension 2000; 35: 173-178.
36. Lawson K. Is there a therapeutic future for ‘potassium channel openers’? Clinical Science 1996: 91: 651-663.
37. Lawson K. Potassium channel activation: A potential therapeutic approach? Pharmacol Ther 1996; 70: 39-63.
38. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995; 268: C799-C822.
39. Ashcroft FM. Ion Channels and Disease: Channelopathies. Academic Press: Ny, 2000.
40. Gribkoff V, Starrett JE Jr, Dworetzsky SI. The pharmacology and molecular biology of large-conductance calcium-activated (BK) potassium channels. In: Adv Pharmacol, Academic Press: Ny, 1997, pp 319-347.
41. Starrett JE, Dworetzky SI, Gribkoff VK. Modulators of large-conductance calcium-activated potassium (BK) channels as potential therapeutic targets. Curr Pharmac Design 1996; 2: 413-428.
42. Dorschner H et al. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. Mol Pharmacol 1999; 55: 1060-1066.
43. Nelson M et al. Relaxation of arterial smooth muscle by calcium sparks. Science 1995; 270: 633-637.
44. Quayle JM, Nelson MT, Standen NB. ATP-Sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 1997; 77: 1165-1232.
45. Jaggar JH, Stevenson AS, Nelson MT. Voltage dependence of Ca2+ sparks in intact cerebral arteries. Am J Physiol 1998; 274: C1755-C1761.
46. Bielefeldt K, Jackson MB. Phosphorylation and dephosphorylation modulate a Ca2+-activated K+ channel in rat peptidergic nerve terminals. J Physiol 1994; 475: 241-254.
47. Chung S et al. Protein kinase A activity closely associated with a reconstituted calcium-activated potassium channel. Science 1991; 253: 560-562.
48. Ileppner TJ, Bonev AD, Nelson MT. Ca2+-activated K+ channels regulate action potential depolarization in urinary bladder smooth muscle. Am JPhysiol 1997; 273: C110-C117.
49. Quast U, Guillon JM, Cavero I. Cellular pharmacology of potassium channel openers in vascular smooth muscle [Review]. Cardiovasc Res 1994; 28: 805-810.
50. Robertson BE, Schubert R, Hescheller J, Nelson MT. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol 1993; 265: C299-C303.
51. Sornlyo AP, Wu X, Walker LA, Somlyo AV. Pharmacome-chanical coupling: The role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Riochem Pharmcol 1999; 134: 202-234.
52. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 213-236.
53. Somlyo AP, Somlyo AV. From pharmacomechanical coupling to G-proteins and myosin phosphatase. Acta Physiol Scand 1998; 164: 437-448.
54. Garland CJ, Angus JA. Pharmacology of Vascular Smooth Muscle. Oxford University Press: New York, 1996.
55. Sleight RG, Lieberman MA. Signal transduction. In: Sper-elakis N, (ed). Cell Physiology Source Rook. Academic Press: Ny, 1998.
56. Sperelakis N, Kuriyarna H. Ion Channels of Vascular Smooth Muscle Cells and Endothelial Cells. Elsevier: Ny, 1991.
57. Catterall YVA. Molecular properties of a superfamily of plasma membrane cation channels. Curr Opinion Cell Riol 1994; 6: 607-615.
58. Noack T, Noack P. Multiple types of ion channels in cavernous smooth muscle. World J Urol 1997; 15: 45-49.
59. Andersson K-E. Clinical pharmacology of potassium channel openers. Pharmacol Toxicol 1992; 70: 244-254.
60. Benevides MD et al. Intracavernosal (IC) injection of a potassium channel opener to treat erectile dysfunction. J Urol 1999; 161(Suppl): 212: (Abstract #812).
61. Bradley KK et al. Klr2.1 encodes the inward rectifier potassium channel in rat arterial smooth muscle cells. J Physiol (Lond.) 1999; 515: 639-651.
62. Aguilar-Bryan L et al. Toward understanding the assembly and structure of KAXP channels. Physiol Rev 1998; 78: 227-245.
63. Babenko AP, Aguilar-Bryan L, Bryan J. A view of SUR/Kir 6.x, KAXP channels. Ann Rev Physiol 1998; 60: 667-687.
64. Erginel-Unaltuna N, Yang WP, Blanar MA. Genomic organization and expression of KCNJ8/Kir6.1, a gene encoding a subunit of an ATP-sensitive potassium channel. Gene 1998; 211: 71-78.
65. Inagaki N et al. Reconstitution of Ikatp: An inward rectifier subunit plus the sulfonylurea receptor. Science 1995; 270: 1166-1170.
66. Inagaki N et al. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem 1995; 270: 5691-5694.
67. Inagaki N, Inazawa J, Seino S. cDNA sequence, gene structure, and chromosomal localization of the human ATP-sensitive potassium channel, uKatp-1, gene (KCNJ8). Genomics 1995; 30: 102-104.
68. Isomoto S et al. A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J Biol Chem 1996; 271: 24321-24324.
69. Seino S. ATP-sensitive potassium channels: A model of heteromultimeric potassium channel/receptor assemblies. Ann Iiev Physiol 1999; 61: 337-362.
70. Stoffel M et al. Cloning of rat KATP-2 channel and decreased expression in pancreatic islets of male zucker diabetic laity rats. Biochem Biophys Bes Comm 1995; 212: 894-899.
71. Dorschner H et al. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. J Pharmacol Exp Ther 1999; 55: 1060-1066.
72. Schwanstecher M et al. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. EMBO J 1998; 17: 5529-5535.
73. McCobb DP et al. Human calcium-activated potassium channel gene expressed in vascular smooth muscle. Am J Physiol 1995; 269: H767-H777.
74. Ferrer J, Wasson J, Salkoff L, Permutt MA. Cloning of human pancreatic islet large conductance Ca2+-activated K+ channel (hSlo) cDNAs: Evidence for high levels of expression in pancreatic islets and identification of a flanking genetic marker. Diabetologia 1996; 39: 891-898.
75. Atkinson NS, Robertson GA, Ganetsky B. A component of calcium-activated potassium channels encoded by the Drosophila slo locus. Science 1991; 253: 551-555.
76. Tseng-Crank J et al. Cloning, expression, and distribution of functionally distinct Ca2+-activated K+ channel isoforms from human brain. Neuron 1994; 13: 1315-1330.
77. Butler A et al. mSlo, a complex mouse gene encoding ‘maxi’ calcium-activated potassium channels. Science 1993; 261: 221-224.
78. Wallner M, Meera P, Toro L. Molecular basis of fast inactivation in voltage and Ca2+-activated K+ channels. A transmembrane β-subunit homolog. Proc Natl Acad Sci 1999; 96: 4137-4142.
79. Jones EMC, Gray-Keller M, Fettiplace R. The role of Ca2+-activated K+ channel spliced variants in the tonotopic organization of the turtle cochlea. J Physiol 1999; 518: 653-665.
80. Rosenblatt KP, Sun ZP, Ileller S, Hudspeth AJ. Distribution of Ca2+-activated K+ channel isoforms along the tonotopic gradient of the chicken’s cochlea. Neuron 1997; 19: 1061-1075.
81. Rainanathan K et al. A molecular mechanism for electrical tuning of cochlear hair cells. Science 1999; 283: 215-217.
82. Adelman JP et al. Calcium-activated potassium channels expressed from cloned complementary DNAs. Neuron 1992; 9: 209-216.
83. Toro L, Wallner M, Meera P, Tanaka Y. Maxi-KCa, a unique member of the voltage-gated K channel superfamily. News Physiol Sci 1998; 13: 112-117.
84. Tseng-Crank J et al. Cloning, expression, and distribution of a Ca2+-activated K+ channel-subunit from human brain. Proc Natl Acad Sci 1996; 93: 9200-9205.
85. Xie J, McCobb DP. Control of alternative splicing of potassium channels by stress hormones. Science 1998; 280: 443-446.
86. Knaus HG et al. Distribution of high-conductance Ca2+-activated K+ channels in rat brain: Targeting to axons and nerve terminals. J Neuroscience 1996: 16: 955-963.
87. Jiang Z, Wallner M, Meera P, Toro L. Human and rodent rnaxi-K channel β-subunit genes: Cloning and characterization. Genomics 1999; 55: 57-67.
88. Saito M, Nelson C, Salkoff L, Lingle CJ. A cysteine-rich domain defined by a novel exon in a Slo variant in rat adrenal chromaffin cells and PC12 cells. J Biol Chem 1997; 272: 11710-11717.
89. Tanaka Y et al. Molecular constituents of maxi KCa channels in human coronary smooth muscle: Predominant ot + fi subunit complexes. J Physiol 1997; 502: 545-557.
90. Palmer L et al. Characterization of cAMP accumulation in cultured human corpus cavernosum smooth muscle cells. J Urol 1994; 152: 1308-1314.
91. Cahn DJ, Melinan A, Valcic M, Christ GJ. Forskolin: A promising new adjunct to intracavernous pharmacotherapy. J Urol 1996; 155: 1789-1794.
92. Gilula NB. Gap Junction-Mediated Intercellular Signaling in Health and Disease. John Wiley & Sons: Ny, 1999.
93. Brink PR, Valiunas V, Christ GJ. Homotypic, heterotypic and heteromeric gap junction channels. In: Perachia C, (ed). Current Topics in Membranes, Vol 49. Academic Press: Ny, 2000, pp 43-60.
94. Veenstra RD. Ion permeation through connexin gap junction channels: Effects on conductance and selectivity. In: Perachia C, (ed). Current Topics in Membranes, Vol 49. Academic Press: Ny, 2000, pp 95-130.
95. Christ GJ et al. Gap junctions in vascular tissues: Evaluating the role of intercellular communication to the modulation of vasomotor tone. Circ Res 1996; 79: 631-646.
96. Campos de Carvalho AC et al. Gap junctions formed of connexin43 interconnect smooth muscle cells of the human corpus cavernosum. J Urol 1993; 149: 1568-1575.
97. Serels S et al. Molecular studies of connexin 43 (Cx43) expression in isolated corporal tissue strips and cultured corporal smooth muscle cells. Int J Impot Res 1998; 10: 1-9.
98. Moreno AP, Campos de Carvalho AC, Christ GJ, Spray DC. Gap junctional communication between human corpus cavernosum smooth muscle cells in culture: Gating behavior and single channel events. Am J Physiol 1993; 264: C80-C92.
99. Christ GJ, Brink PR. An analysis of the presence and physiological relevance of subconducting states of connex-in43-derived gap junction channels in cultured human corporal vascular smooth muscle cells. Circ Res 1999; 84: 797-803.
100. Brink PR, Ramanan SV, Christ GJ. Human connexin43 gap junction channel gating: Evidence for mode shifts and/or heterogeneity. Am J Physiol 1996; 271: C321-C331.
101. Christ GJ et al. Intercellular communication through gap junctions: A potential role in pharmacomechanical coupling and syncytial tissue contraction in vascular smooth muscle isolated from the human corpus cavernosum. Life Sci 1991; 49: 195-200.
102. Christ GJ. The ‘syncytial tissue triad’: The mechanistic basis for integrative tissue physiology. Einstein Quarterly J Biol Med 1999; 15: 179-191.
103. Ramanan SV, Brink PR, Christ GJ. Neuronal innervation, intracellular signal transduction and intercellular coupling: A model for syncytial tissue responses in the steady state. J Theor Biol 1998; 193: 69-84.
104. Christ GJ, Brink PR, Ramanan SV. Dynamic gap junctional communication: A delimiting model for tissue responses. Biophys J 1994; 67: 1335-1344.
105. Christ GJ et al. K+ channel gene therapy is associated with increased nerve-stimulated intracavernous pressure (ICP) responses despite diminished neuronal innervation following 3-4 months of experimental diabetes in rats. FASEB J 1999; 13: A192.
106. Day NS et al. hSlo transcript is locally restricted after a single intracavernous injection of naked hSlo/pcDNA. FASEB J 1999; 13: A356.